Clinical trial
A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment
NCT05708352 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 27, 2023
- Completion date
- September 30, 2029
- Enrollment
- 170 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma multiforme